β¨ Fisheries and Health Notices
2862 NEW ZEALAND GAZETTE, No. 108 4 OCTOBER 2007
consent is given for Westhaven Shellfish Limited to hold quota shares for deepwater clam having a combined quota weight less than or equal to 80 percent of the combined total allowable commercial catches of deepwater clam.
- Restriction on holding quota shares in other deepwater clam stockβThe consent given in clause 3 is subject to the following conditions:
(a) Westhaven Shellfish Limited does not hold quota shares for any deepwater clam stock other than deepwater clam in quota management area 7 (PZL7); and
(b) Westhaven Shellfish Limited does not hold more than 80,000,000 quota shares for deepwater clam in quota management area 7 (PZL7).
- RevocationβThe Fisheries (Quota Aggregation Limit Exemption) Notice 2007 (No. F401) published in the New Zealand Gazette, 29 March 2007, No. 35, page 900, is revoked.
Dated at Wellington this 1st day of October 2007.
HON. JIM ANDERTON, Minister of Fisheries.
go6903
Health
Medicines Act 1981
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product: Remicade
Active Ingredient: Infliximab 100mg
Dosage Form: Powder for infusion concentrate
New Zealand Sponsor: Schering-Plough a division of Schering-Plough Animal Health Limited
Manufacturers: Cilag AG, Schaffhausen, Switzerland
Parkedale Pharmaceuticals Inc, Rochester, Michigan, United States of America
Patheon Italia SpA, Viale G.B. Monza, Milan, Italy
Schering-Plough Company, Brinny, Innishannon, County Cork, Ireland
Product: BeneFIX
Active Ingredient: Nonacog alfa 1,000IU
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Wyeth Farma S.A., Ctra de Madrid-Burgos, San Sebastian de los Reyes, Madrid, Spain
Product: BeneFIX
Active Ingredient: Nonacog alfa 250IU
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Wyeth Farma S.A., Ctra de Madrid-Burgos, San Sebastian de los Reyes, Madrid, Spain
Product: BeneFIX
Active Ingredient: Nonacog alfa 500IU
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Wyeth Farma S.A., Ctra de Madrid-Burgos, San Sebastian de los Reyes, Madrid, Spain
Dated this 27th day of September 2007.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).
go6823
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2007, No 108
Gazette.govt.nz —
NZ Gazette 2007, No 108
β¨ LLM interpretation of page content
πΎ
Fisheries (Quota Aggregation Limit Exemption) Notice (No 2) 2007
(continued from previous page)
πΎ Primary Industries & Resources1 October 2007
Fisheries Act, Quota Aggregation Limit Exemption, Deepwater Clam, Westhaven Shellfish Limited
- Jim Anderton (Honourable), Minister of Fisheries
- HON. JIM ANDERTON, Minister of Fisheries
π₯ Consent to the Distribution of Changed Medicines
π₯ Health & Social Welfare27 September 2007
Medicines Act, Remicade, Infliximab, BeneFIX, Nonacog alfa, Schering-Plough, Wyeth (NZ) Limited
- ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social WelfareMedicines Act, New Medicines